adenylosuccinate has been researched along with Muscular Dystrophy, Duchenne in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campelj, DG; Goodman, CA; Hayes, A; Rybalka, E; Timpani, CA | 1 |
1 other study(ies) available for adenylosuccinate and Muscular Dystrophy, Duchenne
| Article | Year |
|---|---|
Adenylosuccinic acid: a novel inducer of the cytoprotectant Nrf2 with efficacy in Duchenne muscular dystrophy.
Topics: Adenosine Monophosphate; Animals; Disease Models, Animal; Humans; Mice; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystrophy, Duchenne; NF-E2-Related Factor 2 | 2021 |